ALTO Alto Ingredients, Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ALTO Stock | Fundamental Analysis & Investment Insights
NASDAQ
Basic Materials
Specialty Chemicals
Current Price
Live
$4.66
Analyst Target
$5.0
+7.3%
Upside
52W High
$4.89
52W Low
$0.76
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
75%
Analysis Accuracy
ALTO's deterministic health scores reveal significant concerns: a Piotroski F-Score of 2/9 indicates weak financial health, and the absence of an Altman Z-Score raises distress risk concerns. Despite this, the stock trades at a discount to its Graham Number ($3.38) and intrinsic value ($1.12), suggesting potential undervaluation. The recent earnings surprise history is volatile but highly positive in the most recent quarters, with a 75% Q/Q EPS growth and 149% YoY EPS growth. Strong price momentum—253% 1-year return and 294.9% 6-month return—reflects market optimism, supported by a strong-buy analyst consensus. However, the company's negative revenue growth (-1.90% YoY) and minimal profitability (1.45% profit margin) remain critical red flags. Price trades at a 37.9% premium to fair value estimate ($3.38), limiting near-term upside from a valuation perspective.
Key Strengths
Recent earnings surprises are exceptionally strong, with a 623.24% average surprise over the last four quarters
Significant EPS growth (149.1% YoY, 75% Q/Q) indicates improving profitability despite weak revenue trends
Stock trades below Graham Number ($3.38) and intrinsic value ($1.12), suggesting potential undervaluation
Strong technical momentum with 294.9% 6-month return and 253% 1-year return
Analyst consensus is strong_buy, with a target price of $5.00, implying upside potential
Key Risks
Piotroski F-Score of 2/9 signals weak financial health and poor operational efficiency
Negative revenue growth (-1.90% YoY) and low profitability (1.45% margin) indicate underlying business challenges
No Altman Z-Score available, raising unquantified bankruptcy risk concerns
High P/E ratio (29.12) and lack of PEG ratio suggest valuation may be stretched relative to earnings growth
Dividend strength is zero, and no cash flow or debt data is available, limiting financial transparency
AI Fair Value Estimate
Based on comprehensive analysis
$3.38
-27.5% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ALTO against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ALTO from our newsroom.
Newest → oldest
No matching news yet.